Yan Amy R, Srivastava Pratyaksh K, Vucicevic Darko, Agarwal Manyoo A, Ziaeian Boback, Fonarow Gregg C, Nsair Ali, Shahandeh Negeen
Cardiology, The Bishop's School, La Jolla, USA.
Cardiology, Ahmanson-UCLA Cardiomyopathy Center, University of California Los Angeles, Los Angeles, USA.
Cureus. 2025 Sep 7;17(9):e91788. doi: 10.7759/cureus.91788. eCollection 2025 Sep.
Heart failure (HF) disproportionately impacts minority groups in the United States. Among minorities living with HF, disparities exist in treatment, access to advanced therapies such as durable left ventricular assist devices and heart transplantation, and outcomes. Reasons for observed disparities range from the prevalence of traditional cardiovascular risk factors to social determinants of health, including housing, access to healthcare, and socioeconomic status. Clinical practice guidelines frequently are unable to address these observed disparities, and clinical trials often underrepresent minority populations. Custom programs tailored toward addressing disparities in HF care are needed to help improve outcomes in minority populations.
心力衰竭（HF）对美国少数族裔群体的影响尤为严重。在患有HF的少数族裔中，治疗、获得诸如耐用左心室辅助装置和心脏移植等先进疗法以及治疗结果方面存在差异。观察到的差异原因从传统心血管危险因素的流行到健康的社会决定因素，包括住房、医疗保健可及性和社会经济地位。临床实践指南常常无法解决这些观察到的差异，而且临床试验中少数族裔人群的代表性往往不足。需要制定专门针对解决HF护理差异的定制计划，以帮助改善少数族裔人群的治疗结果。
